Cleansing Notice — Rights Issue

Sep 24, 2018
Posted in: Investor updates

Home » Cleansing Notice — Rights Issue

Cleansing Notice — Rights Issue

Sep 24, 2018
Posted in: Investor updates

Imagion Biosystems has lodged Pro-Rata Non-Renounceable Rights Issue: Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth) with the Australian Securities Exchange.
View the Pro-Rata non-Renounceable Rights Issue announcement.

Imagion Biosystems receives AU$3.5 million in R&D tax incentives

September 19, 2023

MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it

1H2023 Half-Year Results

August 30, 2023

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Shareholder Letter from CEO July 2023

July 31, 2023

Dear Imagion Biosystems Shareholders, It has been an incredible first month ramping up as Chief Executive Officer with Team Imagion Biosystems. With this quarter’s 4C

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Cleansing Notice — Rights Issue

Cleansing Notice — Rights Issue

Related Articles

Imagion Biosystems receives AU$3.5 million in R&D tax incentives

1H2023 Half-Year Results

Shareholder Letter from CEO July 2023

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list